We found that MET exon 14 skipping mutation was significantly associated with older age (P = 0.001), and there was no measurable significance between MET exon 14 skipping and MET exon 14 skipping wildtype for sex, tumor stage, tumor location, smoking, histology type, and pleural invasion. Here, MET is linked to neoplasm.